Amyotrophic lateral sclerosis (ALS) - Market Outlook Report - 2020 To 2030

Amyotrophic lateral sclerosis (ALS) - Market Outlook Report - 2020 To 2030

Market Research Software by Thelansis Knowledge Partners

See who's skilled in this

Add as skill Learn more

About

Comprehensive insight on patient segmentation based on age, sex, mutation type (SOD1 mutations, TARDBP mutation, TDP-43, C9orf72 and others); onset sites according to handedness and footedness (divided into right and non-right dominant, Co-morbidities (coronary heart disease, arterial hypertension, myocardial infarction, diabetes mellitus, hypercholesterolemia & Others), Symptoms (Dysphagia, Dyspnoea, Pain, Dysarthria, Cognitive changes, Sialor-rhoea, Thickened saliva, Emotional lability, Depression and anxiety and Others), Amyotrophic lateral sclerosis (ALS) and its treatment in the 8 MM countries, covering the United States, EU5 (Germany, Spain, France, Italy, UK), Japan, and China

Media

Similar products

Thelansis Knowledge Partners products